{
    "organizations": [],
    "uuid": "f5acefe636657dc842481fb1c1efc5bbd263b145",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-faron-pharmaceuticals-says-us-fda/brief-faron-pharmaceuticals-says-u-s-fda-approved-investigational-nda-for-traumakine-idUSFWN1PJ01K",
    "ord_in_thread": 0,
    "title": "BRIEF-Faron Pharmaceuticals Says ‍U.S. FDA Approved Investigational NDA For Traumakine​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Faron Pharmaceuticals Oy:\n* ‍US FOOD AND DRUG ADMINISTRATION HAS APPROVED INVESTIGATIONAL NEW DRUG APPLICATION FOR TRAUMAKINE​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)\n ",
    "published": "2018-01-24T15:38:00.000+02:00",
    "crawled": "2018-01-25T13:04:06.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "faron",
        "pharmaceutical",
        "oy",
        "food",
        "drug",
        "administration",
        "approved",
        "investigational",
        "new",
        "drug",
        "application",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}